Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference

We held an international consensus conference on frontotemporal dementia, behavioral disturbances, and parkinsonism linked to chromosome 17 to determine whether these are homogeneous or heterogeneous disorders, to agree on terminology, and to develop strategies for further research. The group identified 13 kindreds with sufficient evidence for linkage, finding in common to all a critical 2 cM between markers D17S791 and D17S800. There was agreement that (1) despite previous descriptions that have emphasized one or another clinical or neuropathological feature, the kindreds share clinical and neuropathological features; (2) until more specific information about the genetic defects becomes available, this disorder is best termed frontotemporal dementia and parkinsonism linked to chromosome 17; and (3) further research will be enhanced by identifying the gene responsible for this disorder, detecting additional cases within known families and, in new families, correlating mutations with phenotypes and more fully delineating the clinical, neuropsychological, and neuropathological characteristics of this disorder.

[1]  J. Groen,et al.  Hereditary Pick's disease: second re-examination of the large family and discussion of other hereditary cases, with particular reference to electroencephalography, a computerized tomography. , 1982, Brain : a journal of neurology.

[2]  M. Hallett,et al.  Haplotype analysis at the DYT1 Locus in ashkenazi jewish patients with occupational hand dystonia , 1996, Movement disorders : official journal of the Movement Disorder Society.

[3]  J. Hardy,et al.  Familial non-specific dementia maps to chromosome 3. , 1995, Human molecular genetics.

[4]  F. Gaughran,et al.  Familial dementia with Pick's cells – a case report of probable familial Pick's disease , 1994, Irish Journal of Psychological Medicine.

[5]  A. Heyman,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1993, Neurology.

[6]  K. Marder,et al.  Clinical characteristics of a family with chromosome 17‐linked disinhibition‐dementia‐ parkinsonism‐amyotrophy complex , 1994, Neurology.

[7]  D. Knopman,et al.  Overview of dementia lacking distinctive histology: pathological designation of a progressive dementia. , 1993, Dementia.

[8]  P. Heutink,et al.  Hereditary frontotemporal dementia is linked to chromosome 17q21—q22: A genetic and clinicopathological study of three dutch families , 1997, Annals of neurology.

[9]  H. Schaumburg,et al.  Non-specific familial presenile dementia. , 1968, Journal of neurology, neurosurgery, and psychiatry.

[10]  A J Lees,et al.  Familial progressive supranuclear palsy. Description of a pedigree and review of the literature. , 1995, Brain : a journal of neurology.

[11]  R. Defendini,et al.  The neuropathology of chromosome 17‐linked dementia , 1996, Annals of neurology.

[12]  A Brun,et al.  Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology. , 1987, Archives of gerontology and geriatrics.

[13]  G. Pals,et al.  Localization of the gene for rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration to chromosome 17q21. , 1996, Human molecular genetics.

[14]  David W. Johnson,et al.  Joining Together: Group Theory and Group Skills , 1975 .

[15]  J. Parisi,et al.  Familial dementia of adult onset with pathological findings of a 'non-specific' nature. , 1981, Brain : a journal of neurology.

[16]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[17]  M. Pericak-Vance,et al.  Linkage of frontotemporal dementia to chromosome 17: clinical and neuropathological characterization of phenotype. , 1996, American journal of human genetics.

[18]  L. Gustafson,et al.  Clinical picture of frontal lobe degeneration of non-Alzheimer type. , 1993, Dementia.

[19]  V. W. Schenk.  RE‐EXAMINATION OF A FAMILY WITH PICK'S DISEASE , 1959, Annals of human genetics.

[20]  R. Crowther,et al.  Comparison of the neurofibrillary pathology in Alzheimer’s disease and familial presenile dementia with tangles , 1996, Acta Neuropathologica.

[21]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology Confirmation of the Clinical Diagnosis of Alzheimer's Disease , 1995, Neurology.

[22]  F. Dark.  A Family with Autosomal Dominant, Non-Alzheimer's Presenile Dementia , 1997, The Australian and New Zealand journal of psychiatry.

[23]  Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[24]  R. Rodnitzky,et al.  Histological and biochemical pathology in a family with autosomal dominant Parkinsonism and dementia , 1993 .

[25]  Z. Wszolek,et al.  Examination of the presynaptic dopaminergic system using positron emission tomography in a famly with autosomal dominant parkinsonism and dementia due to pallido-ponto-nigral degeneration (PPNO) , 1993 .

[26]  D. Knopman,et al.  Dementia lacking distinctive histologie features , 1990, Neurology.

[27]  J. Pastor,et al.  Blood groups of the Cantabrian population (Spain). , 1992, Human heredity.

[28]  J. Groen,et al.  HEREDITARY PICK'S DISEASE , 1982 .

[29]  David W. Johnson,et al.  Joining together: Group theory and group skills, 5th ed. , 1994 .

[30]  W. Markesbery,et al.  Familial progressive subcortical gliosis , 1995, Neurology.

[31]  B. Snow,et al.  Rapidly progressive autosomal dominant parkinsonism and dementia with pallido‐ponto‐nigral degeneration , 1992, Annals of neurology.

[32]  J. Coyle,et al.  Primary Degenerative Dementia Without Alzheimer Pathology , 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[33]  W. Markesbery,et al.  Familial progressive subcortical gliosis , 1994, Neurology.

[34]  S. M. Sumi,et al.  Familial presenile dementia with psychosis associated with cortical neurofibrillary tangles and degeneration of the amygdala , 1992, Neurology.

[35]  M. Mendez,et al.  Risk factors in Alzheimer's disease , 1992, Neurology.

[36]  Z. Wszolek,et al.  Familial parkinsonism: Our experience and review. , 1995, Parkinsonism & related disorders.

[37]  K. Wilhelmsen,et al.  Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. , 1994, American journal of human genetics.

[38]  A. Brun,et al.  Frontal lobe degeneration of non‐Alzheimer type , 1992, Bailliere's clinical neurology.